Dermal delivery device
Abstract:
A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of less than 5% and/or achieves a meaningful degree of detachment over a seven day period of less than 20%.
Public/Granted literature
Information query
Patent Agency Ranking
0/0